RBC Capital analyst Paul Treiber reiterates Info Servs (TSX:ISV) with a Sector Perform and maintains C$26 price target.
Why Tonix Pharmaceuticals Stock (TNXP) Is Getting Obliterated
Tonix Pharmaceuticals shares are trading lower by 22.3% Thursday afternoon. The company announced the pricing of a $4.4 million registered direct offering.